We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current RPID market cap is 32.72M. The company's latest EPS is USD -1.2346 and P/E is -0.62.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.04M | 5M | 6.15M | 6.34M | 5.61M |
| Operating Income | -14.87M | -15.05M | -14.45M | -12.19M | -14.27M |
| Net Income | -13.89M | -14.02M | -13.39M | -11.17M | -13.32M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 16.51M | 16.08M | 23.23M | 17.13M | 22.52M |
| Operating Income | -18.63M | -30.54M | -47.23M | -63.22M | -56.56M |
| Net Income | -26.62M | -45.22M | -78.03M | -60.81M | -52.47M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 173.28M | 160.95M | 150.16M | 143.45M | 127.73M |
| Total Liabilities | 20.84M | 21.32M | 22.38M | 25.46M | 21.79M |
| Total Equity | 152.44M | 139.63M | 127.79M | 117.99M | 105.94M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 31.69M | 70M | 241.17M | 190.65M | 143.45M |
| Total Liabilities | 32.41M | 45.18M | 20.19M | 26.48M | 25.46M |
| Total Equity | -82.58M | -127.01M | 220.98M | 164.17M | 117.99M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.69M | -25.88M | -35.58M | -45.08M | -15.53M |
| Investing | 13.91M | 27.38M | 32.15M | 42.15M | 13.52M |
| Financing | 122k | 113k | 161k | 149k | 158k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.15M | -31M | -54.96M | -58.55M | -45.08M |
| Investing | -1.7M | -15.67M | -13.29M | -93.47M | 42.15M |
| Financing | 14.87M | 64.23M | 216.75M | 693k | 149k |
| Market Cap | 32.72M |
| Price to Earnings Ratio | -0.62 |
| Price to Sales Ratio | 1.45 |
| Price to Cash Ratio | 1.35 |
| Price to Book Ratio | 0.28 |
| Dividend Yield | - |
| Shares Outstanding | 42.5M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.1 (12.2%) |
| Company Name | Rapid Micro Biosystems Inc |
| Address |
251 little falls drive delaware, ohio 19808 |
| Website | https:///www.rapidmicrobio.com |
| Industry | lab analytical instruments (3826) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
